European Drug Report 2013: Trends and developments
An estimated 3 million Europeans from 15 to 64 years use cannabis on a daily, or almost daily, basis according to the European Drug Report 2013, published today by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Latest data show how herbal cannabis (‘marijuana’), sometimes of high potency, is becoming more common in Europe, with almost all of the EMCDDA countries now reporting some domestic cultivation of this product.
In its annual review, the agency describes positive developments in relation to the more established drugs, such as fewer new users of heroin, less injecting and declining use of cannabis and cocaine in some countries. But these are offset by concerns over synthetic stimulants and new psychoactive substances, offered both on the illicit, and so-called ‘legal highs’, market.
Find out more here: http://www.emcdda.europa.eu/edr2013